96359 ⎘
Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond Acyclic radicals
Sub-classes:ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS
#2ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS
#3Methyl Fructoside Polyether Amine, Preparation Method Therefor and Use Thereof
#4ASGPR-binding compounds for the degradation of extracellular proteins
#5ADVANCED GLYCATION END PRODUCT ANALOGUES
#6ASGPR-binding compounds for the degradation of extracellular proteins
#7ASGPR-binding compounds for the degradation of extracellular proteins
#8MANNOSE 6-PHOSPHATE OR ASGPR RECEPTOR BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS
#9Sugar Derivatives and Uses Thereof to Prepare Novel Senolytic Agents
#10ASGPR-binding compounds for the degradation of extracellular proteins
#11METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID
#12SYNTHESIS OF C-GLYCOSIDES OF INTEREST
#13MODIFIED VIRAL COMPOSITIONS FOR VIRAL TRANSDUCTION
#14METHOD OF PRODUCING ALIPHATIC GLYCOSIDE COMPOUND OR SUGAR FATTY ACID ESTER COMPOUND
#15ANTIBACTERIAL AND ANTIFUNGAL POLYKETIDES FROM ENVIRONMENTAL AMYCOLATOPSIS SPP
#16ASGPR-binding compounds for the degradation of extracellular proteins
#17Sugar derivatives and uses thereof to prepare novel senolytic agents
#18Mannose derivatives for treating bacterial infections
#19Compound or salt thereof
#20METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID
#21C-glycoside amine derivatives and methods of making
#22Method for preparing intermediate by reduced glutathione-indicated amino acid maillard reaction
#23TCO conjugates and methods for delivery of therapeutic agents
#24Advanced glycation end product analogues
#25Inhibitors of the shikimate pathway
#262,7-dibromospiro[fluorene-9,4′-piperidine] compounds
#27Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#28Sialic acid analogs
#29Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#30Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating induced inflammatory bowel diseases such as crohn's disease
#31Novel Compounds and Compositions and Methods of Use
#32Sialic acid analogs
#33TCO conjugates and methods for delivery of therapeutic agents
#34Mannose derivatives for treating bacterial infections
#35Process for treating keratin materials using amide, acid or ester c-glycoside derivatives, and cosmetic composition containing same
#36ADVANCED GLYCATION END PRODUCT ANALOGUES
#37Sugar-dipeptide conjugates as flavor molecules
#38Environmentally friendly gelator using medium chain triglycerides and method of use
#39Compounds and compositions and methods of use
#40Crystal of alkali metal N-acetylneuraminate anhydrate, and process for producing same
#41COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING OR ELIMINATING BITTER TASTE
#42TCO conjugates and methods for delivery of therapeutic agents
#43Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#44TCO conjugates and methods for delivery of therapeutic agents
#45Glycopeptide derivatives for the preservation and protection of biological materials and microorganisms
#46Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating induced inflammatory bowel diseases such as crohn's disease
#47Probes and methods of imaging a bacterial infection
#48Sialic acid analogs
#49Mannose derivatives for treating bacterial infections
#50NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USE
#51Glycan conjugates and methods of use thereof
#52Synthetic antigen constructs against
#53Carbohydrate phosphonate derivatives as modulators of glycosylation
#54Glycomimetics as lectin inhibitors
#55ADVANCED GLYCATION END PRODUCT ANALOGUES
#56hDC-sign binding peptides
#57Coferons and methods of making and using them
#58Sialic acid analogs
#59Glycosylated antitumor ether lipids as novel cancer stem cell cytotoxic agents
#60Method of detecting cancer based on glycan biomarkers
#61Mannose derivatives for treating bacterial infections
#62Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#63Gem-difluorinated C-isopropylgalactoside derivates
#64Method for producing diester of polyhydric alcohol and fatty acid
#65Derivatives of glyco-CF-serine and glyco-CF-threonine
#66Sialic acid analogs
#67MONOSACCHARIDE-BASED COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE AND INFLAMMATORY DERMATOLOGICAL DISEASES
#68Linkable Lewis X Analogs
#69Amphiphilic compositions and methods for preparing and using same
#70Compounds and compositions and methods of use
#71Compounds and compositions and methods of use
#72Compounds and compositions and methods of use
#73Coferons and methods of making and using them
#74Chemoselective ligation
#75LINKABLE LEWIS X ANALOGS
#76EXTRACTION METHOD FOR SIALIC ACID-CONTAINING COMPOUND FROM PLANT
#77NOVEL USES OF D-MANNOPYRANOSE DERIVATIVES
#78Methods and compositions for treating diseases and disorders associated with siglec-8.
#79Synthesis of metabolically stable analgesics, pain medications and other agents
#80Bis-modified bicyclic nucleic acid analogs
#811,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof
#821,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof
#834-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl]benzoic acid analogs and method of manufacture and use thereof
#84AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure
#85CELLULOSIC SUBSTANCE COMPOSITION, CELLULOSIC SUBSTANCE FILM, OPTICALLY COMPENSATORY FILM, POLARIZING PLATE AND IMAGE DISPLAY DEVICE
#86Compounds and compositions and methods of use
#87Bis-modified bicyclic nucleic acid analogs
#88Linkable Lewis X Analogs
#89Chemoselective ligation
#90Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#91Methods and compositions for treating diseases and disorders associated with Siglec-8 expressing cells
#92Method for the production of 2-keto-l-gulonic acid esters
#93Treatment of diseases associated with the egr-1 enhancer element
#94Chemoselective ligation
#954-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl]benzoic acid analogs and method of manufacture and use thereof
#96Chemoselective ligation
#97Process for preparation of sulfamide derivatives
#98AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure
#99AI-2 compounds and analogs based on LsrB structure
#100Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
#101Novel synthetic C-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases
#102Chemoselective ligation
#103Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
#104Process for the production of 2-C-methyl-D-ribonolactone
#105Compounds and methods for treating osteoarthritis